Signe Caksa

Immunology and MicrobiologyBiochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Hip Structural Analysis Reveals Impaired Hip Geometry in Girls With Type 1 Diabetes”.

Hip Structural Analysis Reveals Impaired Hip Geometry in Girls With Type 1 Diabetes

The Journal of Clinical Endocrinology & Metabolism(2020)10.1210/clinem/dgaa647

N/A

1.0DataRank · unranked

21 citations

Signe Caksa, Madhusmita Misra, Deborah M. Mitchell, Taïsha Joseph

Gene signature reveals decreased SOX10-dependent transcripts in malignant cells from immune checkpoint inhibitor-resistant cutaneous melanomas

iScience(2023)10.1016/j.isci.2023.107472

N/A

0.438DataRank · unranked

11 citations

Signe Caksa, Ahmet Saçan, Claudia Capparelli, Andrew E. Aplin, Timothy J. Purwin

A β-Catenin-TCF-Sensitive Locus Control Region Mediates GUCY2C Ligand Loss in Colorectal Cancer

Cellular and Molecular Gastroenterology and Hepatology(2021)10.1016/j.jcmgh.2021.12.014

N/A

0DataRank · unranked

12 citations

Ariana A. Entezari, Adi Caspi, Signe Caksa, Aakash Jhaveri, Timothy J. Stanek +8 more

Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma

Nature Communications(2022)10.1038/s41467-022-28801-y

N/A

0DataRank · unranked

100 citations

Timothy J. Purwin, McKenna Q. Glasheen, Signe Caksa, Manoela Tiago, Nicole A. Wilski +17 more

The future of targeted kinase inhibitors in melanoma

Pharmacology & Therapeutics(2022)10.1016/j.pharmthera.2022.108200

N/A

0DataRank · unranked

33 citations

Usman Baqai, Andrew E. Aplin, Signe Caksa

Targeting Upregulated cIAP2 in SOX10-Deficient Drug Tolerant Melanoma

Molecular Cancer Therapeutics(2023)10.1158/1535-7163.mct-23-0025

N/A

0DataRank · unranked

13 citations

Signe Caksa, Amelia G. Young, Nicole A. Wilski, Connor A. Ott, Inna Chervoneva +6 more

SOX10 Loss Sensitizes Melanoma Cells to Cytokine-Mediated Inflammatory Cell Death

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-23-0290

N/A

0DataRank · unranked

13 citations

Signe Caksa, Casey D. Stefanski, Isabella V. Trachtenberg, Haley P. Wilson, Nicole A. Wilski +9 more

Total Calcium Intake Is Associated With Trabecular Bone Density in Adolescent Girls With Type 1 Diabetes

JBMR Plus(2023)10.1002/jbm4.10813

N/A

0DataRank · unranked

6 citations

Kathleen M. Kilroe, Taïsha Joseph, Signe Caksa, Mary Bouxsein, Madhusmita Misra +2 more

Aqueous humor biomarkers in ocular oncology: Insights and advances

Cell Reports Medicine(2025)10.1016/j.xcrm.2025.102447

N/A

0DataRank · unranked

4 citations

Signe Caksa, Rachel E Cain, Scott A. Waldman, Andrew E. Aplin, Lara Cheslow

Elevated Transglutaminase-2 in SOX10-Deficient Melanoma Promotes Tumor Onset and Decreases Intratumoral CD4+ T Cells

Cancer Research(2025)10.1158/0008-5472.can-24-3267

N/A

0DataRank · unranked

2 citations

Timothy J. Purwin, Dan A. Erkes, Kristen M. DeRosa, Erica Kitterman, Samantha M. Barnada +13 more

Pyroptosis Modulates Multiple Immune Cell Populations in Targeted Therapy–Treated Melanoma

Cancer Immunology Research(2025)10.1158/2326-6066.cir-25-0444

N/A

0DataRank · unranked

2 citations

Dan A. Erkes, Timothy J. Purwin, Diana S. Melissaratos, Casey D. Stefanski, Signe Caksa +7 more

SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects

Cell Reports(2021)10.1016/j.celrep.2021.110085

N/A

0DataRank · unranked

39 citations

Manoela Tiago, Signe Caksa, Claudia Capparelli, Timothy J. Purwin, Gaurav Kumar +6 more